Skip to main content
. 2019 Feb 15;11(2):991–997.

Figure 1.

Figure 1

The antitumor effect of combined treatment with ATO and GEM. Pancreatic cancer cells were treated with either 3 µM arsenic trioxide (ATO) or 20 µM GEM, or co-treated with 3 µM ATO and 20 µM gemcitabine (GEM) for 48 h, and the number of viable cells was determined using the MTT assay. Vertical bars indicate the means ± SD of three independent experiments. Both: ATO plus GEM. *P < 0.05 compared with the control; #P < 0.05 compared with ATO alone or GEM alone.